PROCEPT BioRobotics Corp (PRCT)
72.66
-1.65
(-2.22%)
USD |
NASDAQ |
Oct 04, 16:00
72.65
-0.01
(-0.01%)
After-Hours: 20:00
PROCEPT BioRobotics SG&A Expense (Annual): 131.77M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 131.77M |
| December 31, 2022 | 88.83M |
| December 31, 2021 | 51.04M |
| Date | Value |
|---|---|
| December 31, 2020 | 30.27M |
| December 31, 2019 | 28.52M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
28.52M
Minimum
2019
131.77M
Maximum
2023
66.09M
Average
51.04M
Median
2021
SG&A Expense (Annual) Benchmarks
| Boston Scientific Corp | 5.19B |
| Intuitive Surgical Inc | 1.964B |
| Perspective Therapeutics Inc | 21.06M |
| Xtant Medical Holdings Inc | 64.29M |
| Catheter Precision Inc | 17.12M |